interesting......by end of March....annual report
Post# of 36537
(Total Views: 223)
Posted On: 03/04/2019 7:11:57 AM
interesting......by end of March....annual report for Fuse
Chris Reeg:
Absolutely, thank you, Joe. I appreciate the time today. 2018 was a year of
achievements and accomplishments for us as we previously released. We
finalized the acquisition of CPM Medical, which is our core company.
Also, a spine company, Maxim Surgical was another acquisition completed
in August. This was kind of a transition year for us. Our accounting team has
been diligently working through our 2018 audit process and are on target for
filing our 10-K Annual Report for 2018, and before the end of March.
Our attention has also been focused on completing the due diligence process
with Generex. We look forward to 2019. We anticipate another great year
with continued growth and new product launches in spine as well as in
orthopedics.
We at Fuse are excited about the opportunities in the near term and future
with Generex, and the synergies offered by as robust pipeline of subsidiary
offerings. Thank you and back to you, Joe.
Chris Reeg:
Absolutely, thank you, Joe. I appreciate the time today. 2018 was a year of
achievements and accomplishments for us as we previously released. We
finalized the acquisition of CPM Medical, which is our core company.
Also, a spine company, Maxim Surgical was another acquisition completed
in August. This was kind of a transition year for us. Our accounting team has
been diligently working through our 2018 audit process and are on target for
filing our 10-K Annual Report for 2018, and before the end of March.
Our attention has also been focused on completing the due diligence process
with Generex. We look forward to 2019. We anticipate another great year
with continued growth and new product launches in spine as well as in
orthopedics.
We at Fuse are excited about the opportunities in the near term and future
with Generex, and the synergies offered by as robust pipeline of subsidiary
offerings. Thank you and back to you, Joe.
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼